Drug Patent Watch
OCTOBER 1, 2024
In the world of healthcare, few topics spark as much debate and confusion as prescription drug pricing. Have you ever wondered why that little pill in your medicine cabinet costs so much? Let’s dive into the intricate world of pharmaceutical economics and uncover the factors that determine the price tags on our prescriptions.
Bio Pharma Dive
OCTOBER 1, 2024
Medical meetings often feature important clinical trial results, making them barometers of biotech and pharma companies' research progress. Here’s a list of conferences to watch in 2025.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
AuroBlog - Aurous Healthcare Clinical Trials blog
SEPTEMBER 29, 2024
(Engin Akyurt/Pixabay) If you’re in a lot of pain, being told to take deep breaths and accept the sensations in your body might not feel particularly comforting.
Pharmaceutical Technology
OCTOBER 2, 2024
Exscientia detailed how its robotics lab in Oxfordshire, UK is increasing productivity and efficiency in developing new molecules at ELRIG 2024.
Bio Pharma Dive
OCTOBER 1, 2024
Over the next three months, the agency could approve a rival to a fast-selling Pfizer heart drug, a much-debated lung cancer medicine and an addition to Vertex's dominant cystic fibrosis business.
Rethinking Clinical Trials
OCTOBER 3, 2024
In a JAMA Viewpoint published online this week, leaders from the NIH Pragmatic Trials Collaboratory discuss the discordance between the results of pragmatic clinical trials and the implementation of those results in healthcare settings, even in settings that championed the work. Coauthors Richard Platt, Hayden Bosworth, and Gregory Simon posit that, to provide evidence that healthcare systems leaders will actually use, changes are necessary: Trials need to be faster (2 to 3 years) Trials should
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Pharmaceutical Technology
SEPTEMBER 30, 2024
The first needle-free epinephrine nasal spray, Neffy by ARS Pharmaceuticals, represents a significant breakthrough in emergency treatment for type I allergic reactions.
Bio Pharma Dive
OCTOBER 4, 2024
An experimental Alzheimer’s therapy from Cassava Sciences is still being tested in two Phase 3 studies, even as the company has come under regulatory scrutiny.
Rethinking Clinical Trials
OCTOBER 2, 2024
In this Friday’s PCT Grand Rounds, Tyler Winkelman of Hennepin Healthcare and the Hennepin Healthcare Research Institute, and David Johnson of Hennepin County, will present “Health Trends Across Communities – A Novel Health System-Public Health Data Partnership.” The Grand Rounds session will be held on Friday, October 4, 2024, at 1:00 pm eastern.
AuroBlog - Aurous Healthcare Clinical Trials blog
SEPTEMBER 30, 2024
(Aja Koska/E+/Getty Images) Have you ever noticed changes in your eating habits when you are sad, bored or anxious? Many people report eating either more, or less, as a way of helping them to cope when they experience difficult emotions.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Pharmaceutical Technology
OCTOBER 3, 2024
GLP-1 RAs are being recommended on social media, raising questions about who can see the content and what the effects might be.
Bio Pharma Dive
OCTOBER 1, 2024
The company’s official launch comes five months after major investors such as Atlas Venture and Bain Capital filed a Shanghai stock exchange filing for a biotech named “Hercules CM NewCo.
Rethinking Clinical Trials
OCTOBER 1, 2024
The NIH Communities Advancing Research Equity for Health , or CARE for Health , program announced 3 inaugural hubs for its primary care–focused clinical research network. These awards are part of a pilot project to test the feasibility of a research network that expands research opportunities to primary care settings. NIH envisions this approach will accelerate research advances for adoption into everyday healthcare to improve health outcomes and health equity for everyone.
AuroBlog - Aurous Healthcare Clinical Trials blog
OCTOBER 3, 2024
(Roxana Wegner/Getty Images) Fatigue is one of the most frequent and debilitating symptoms of long COVID, and yet it is also one of the hardest to measure objectively. A new study suggests the extreme mental and physical fatigue experienced by many long COVID patients is, in fact, observable in the central nervous system.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Pharmaceutical Technology
OCTOBER 2, 2024
The funds will support the development of LoQus23’s lead candidate, its MutSβ inhibitor, as it enters clinical development.
Bio Pharma Dive
SEPTEMBER 30, 2024
The Swiss pharma is paying Regor Therapeutics $850 million to buy a pair of prospects it sees as potential successors to blockbuster medicines from Pfizer and Eli Lilly.
Rethinking Clinical Trials
SEPTEMBER 30, 2024
The NIH Pragmatic Trials Collaboratory’s Health Equity Core released a new Health Equity in Pragmatic Clinical Trials guide designed to help research teams define health equity and provide examples of how to promote it in clinical research. “Understanding what we mean by health equity is a fundamental step for integrating a health equity lens into research,” said Rosa Gonzalez-Guarda, cochair of the Health Equity Core and an associate professor and assistant dean in the Duke Un
AuroBlog - Aurous Healthcare Clinical Trials blog
OCTOBER 1, 2024
(Bambu Productions/DigitalVision/Getty Images) Of all the advice on preventing hangovers, drinking water to prevent dehydration seems like the most sensible. A new study has found no evidence to support claims that drinking a generous amount of water after a night of boozing alleviates the pain the next day.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharmaceutical Technology
OCTOBER 3, 2024
GLP-1 RAs are being recommended on social media, raising questions about who can see the content and what the effects might be.
Bio Pharma Dive
OCTOBER 3, 2024
Removal of Lilly’s in-demand drugs from the FDA’s shortage list ramps up pressure on the companies selling compounded versions.
Pharma Mirror
SEPTEMBER 29, 2024
In healthcare, safety is always the top priority—whether it's protecting patients or the staff who care for them. Personal protective equipment (PPE) plays a vital role in ensuring this safety, and one item that stands out is nitrile exam gloves. The post Why Nitrile Exam Gloves Are the Preferred Choice for Medical Professionals appeared first on Pharma Mirror Magazine.
AuroBlog - Aurous Healthcare Clinical Trials blog
OCTOBER 2, 2024
(akaratwimages/Canva) High blood pressure (or hypertension) increases the risk of health problems such as heart or kidney failure, but goes undiagnosed in millions of people.
Pharmaceutical Technology
OCTOBER 1, 2024
Otulfi is the fourth Stelara biosimilar approved in the US but will not launch until early 2025.
Bio Pharma Dive
OCTOBER 2, 2024
Biosimilar competition to aging blockbusters will erode a large chunk of the pharma giant’s top line over the next few years.
Fierce Pharma
OCTOBER 1, 2024
Johnson & Johnson is laying off 231 employees in New Jersey and Bayer is cutting 57 positions in the state, according to separate Worker Adjustment and Retraining Notification (WARN)
AuroBlog - Aurous Healthcare Clinical Trials blog
OCTOBER 2, 2024
The Jan Aushadhi Kendras (JAKs) under the flagship scheme of the Department of Pharmaceuticals (DoP), Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP), has reported a growth of 6.
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Pharmaceutical Technology
OCTOBER 1, 2024
BioCryst Pharmaceuticals has received a contract valued at up to $69m from the US Department of Health and Human Services (HHS) for the procurement of RAPIVAB to treat influenza.
Bio Pharma Dive
OCTOBER 4, 2024
Having already been on a winding journey, Enjaymo, which Sanofi acquired through a 2018 buyout of Bioverativ, is now headed to Recordati as part of a deal announced Friday.
Fierce Pharma
OCTOBER 4, 2024
After announcing the closure of its biggest manufacturing site Sunday due to flooding caused by Hurricane Helene, Baxter International—the U.S.’ top supplier of hospital IV fluids—is laying out det | While progress is already being made after Hurricane Helene, which resulted in water “permeating” Baxter’s large IV fluid production plant in North Carolina, the company cautioned that it does not yet have a timeline for when operations will be back online.
AuroBlog - Aurous Healthcare Clinical Trials blog
SEPTEMBER 30, 2024
Researchers see a greater need for new generation therapeutics to propel precision medicine. The development of innovative therapeutic approaches in healthcare encompass a variety of fields, including gene therapy, personalized medicine, immunotherapy, and advanced biologics.
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
Expert insights. Personalized for you.
100 
Let's personalize your content